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Abstract
Background. Diabetes is a widespread public health concern that alters the
metabolism of adipocytes through high glucose stress and hormonal
dysregulation. Under diabetic conditions there are excess nutrients available and
subsequently an accumulation of tricarboxylic acid cycle intermediates such as
fumarate. Fumarate can irreversibly react with protein cysteine residues to form
S-2-succinocysteine (2SC, protein succination). Succinated proteins can be
turned over by autophagy, a mechanism of removing damaged proteins and
organelles that have accumulated due to metabolic stress.
Purpose. The basal flux through autophagy in adipocytes matured in nondiabetic and diabetic conditions was examined to determine the turnover of
succinated proteins. Additionally, fumarase content was reduced using a shRNA
lentiviral knockdown to elevate fumarate levels. This model of enhanced
succination was used to assess autophagic flux and succinated protein turnover
in the total homogenate and enriched fractions of the cytosol, mitochondria, and
nucleus.
Methods. 3T3-L1 fibroblasts were differentiated to adipocytes then matured in
normal or high glucose conditions. Using total cell lysates, I assessed 2SC and
autophagic flux via western blotting. Additionally, I knocked down fumarase (Fh
k/d) in 3T3-L1 fibroblasts, differentiated them to adipocytes, and evaluated
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differences in 2SC and autophagic flux both in the total homogenate and in
individual cellular fractions.
Conclusions. I conclude that succinated proteins are turned over by autophagy,
but that flux through autophagy is reduced under high glucose conditions.
Similarly, when succination is enhanced in adipocytes by Fh k/d, autophagic flux
is reduced. Despite this, succinated protein turnover by autophagy occurs at a
faster rate in the mitochondrial enriched fraction verses other fractions of Fh k/d
adipocytes. These results provide insight on how metabolic dysregulation and
protein modification may contribute to reduced autophagy under diabetic
conditions and confirm the utility of 2SC as a marker for high glucose stress.
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Chapter I
INTRODUCTION
1.1. Public Health Dilemma
Metabolic syndrome is defined as the presence of at least three of the
following: large waistline (≥ 40 inches for men or 35 inches for women), high
triglycerides (≥ 150 mg/dL), low HDL cholesterol (≤ 40 mg/dL for men or 50
mg/dL for women), high blood pressure (systolic ≥ 130 mm Hg or diastolic ≥ 85
mm Hg), and high fasting blood glucose (≥ 100 mg/dL). The presence of these
risk factors indicates increased risk for the development of heart disease,
diabetes, and stroke. Type 2 diabetes mellitus (T2DM) and obesity are
predominantly lifestyle-induced metabolic dysfunctions, derived from the
combined effects of excessive caloric intake and increased sedentary behavior.
Current Centers for Disease Control statistics show that 9.3% of the US
population suffer from diabetes, 28.3% of adults are obese, and an additional
35.5% of adults are overweight (CDC). The prevention and treatment of these
conditions is a national health crisis that requires immediate attention. Since
T2DM and obesity are systemic, their effects on metabolic dysfunction are
observed in many organs including the adipose tissue, liver, and muscle. As the
disease progresses, other organs including the kidneys, heart, and eyes are also
affected by diabetic complications. Therefore, a detailed mechanistic
understanding of the cellular processes contributing to dysregulated metabolism
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in these organs is required. In particular, the importance of maintaining
metabolically healthy adipose tissue has received increased attention
considering its roles in energy storage and hormone production.
1.2. Adipose Tissue
Adipose tissue is a specialized tissue in which the body stores extra
energy as triglycerides or releases free fatty acids in the presence of an energy
deficit. This unique role allows cellular lipid droplet storage without lipotoxicity
(Konige et al. 2014). This process is highly regulated by hormones that respond
to the changing metabolic needs of the body. In the absence of immediately
available nutrients, such as during the fasted state, glucagon and epinephrine will
be released leading to lipolysis and the mobilization of energy-rich fatty acids. In
contrast, during energy surplus, insulin antagonizes fuel mobilization and
promotes the synthesis and storage of triglycerides in the adipocytes. The
significant endocrine function of the adipocyte also contributes to the regulation
of energy balance. Adipocyte hormones (adipokines) are secreted from the
adipocyte and have roles in the regulation of satiety (leptin) and mediating insulin
sensitive effects on muscle and liver (adiponectin) (Diez and Iglesias, 2003).
Therefore, the combined actions of the adipocyte in the storage of surplus energy
and systemic fuel utilization demonstrate its importance in systemic energy
homeostasis.
Adipocyte metabolism is altered in diseases states such as obesity and
T2DM that compromise adipose tissue homeostasis. Obesity is a chronic state of
nutrient excess that results in adipocyte enlargement. This adipocyte hypertrophy
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eventually leads to cell death as well as lipid accumulation in non-adipose tissues
such as muscle and liver (Giordano et al. 2013, Petersen et al. 2005, Sinha et al.
2002). Dying adipocytes release fatty acids into the circulation that can be taken
up by the liver, contributing to hepatic steatosis (Alkhouri et al. 2010). Treatment
with PPARγ agonists, the thiazolidinediones (TZDs), induces adipogenesis and
improves insulin action in both muscle and liver by promoting the redistribution of
fat out of these tissues and into peripheral adipocytes. The induction of PPARγ in
adipocytes alone is sufficient to improve whole-body insulin sensitivity (Lehmann
et al. 1995, Mayerson et al. 2002, Sugii et al. 2009).
The development of T2DM and reduced insulin sensitivity has been linked
to metabolic stresses induced by nutrient excess, when the fuel supply exceeds
the demands of the adipocyte (Keller and Attie, 2010). This results in increased
intra-adipocyte stress in organelles such as the endoplasmic reticulum (ER) and
the mitochondria. (Choo et al. 2006, Frizzell et al. 2012, Gregor and Hotamisligil
2007, Lin et al. 2005). Mitochondrial stress is increased under high glucose
conditions as adipogenesis is occurring (Frizzell et al. 2012, Nagai et al. 2007).
These metabolic stressors produce oxidative stress that induces cellular
dysfunction.
Mitochondrial oxidative stress is believed to have an important role in
mediating adipocyte dysfunction (Frizzell et al. 2012, Lin et al. 2005). These
conditions of oxidative stress can lead to the post-translational modification of
proteins, impairing their normal function. The carbonylation of adipocyte proteins
by hydroxynonenal (HNE), a product of lipid oxidation, has been demonstrated in
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adipocytes under diabetic conditions (Grimsrud et al. 2007, Tang et al. 2012).
Recently, our laboratory has documented a new irreversible protein modification
that is increased in adipocytes in high glucose conditions (see Section 1.3
below). Overall, the investigation of the biochemical changes occurring in the
adipocyte under developing diabetic conditions is necessary to understand the
mechanistic changes that contribute to adipocyte dysfunction. A better
understanding of these pathways will allow us to design better therapeutic
approaches for the management of diabetes and its complications.
1.3. Protein Succination
Protein succination is a chemical modification produced following the
reaction of fumarate with the sulfhydryl group of cysteine to produce a stable
adduct; S-2-succinocysteine (2SC) (Alderson et al. 2006; Figure 1.1). Our
laboratory has demonstrated that cellular stress induced by nutrient excess leads
to an accumulation of succinated proteins. The excess glucose availability
(glucotoxicity) in adipocytes induces mitochondrial stress and leads to the
accumulation of ATP (Figure 1.2). This energy accumulation will feedback and
inhibit oxidative phosphorylation through mitochondrial respiratory control. Since
the membrane potential is elevated, the electron transport chain is inhibited so
that NADH concentration is increased. This increase in NADH/NAD+ ratio inhibits
the NAD+ dependent enzymes of the tricarboxylic acid cycle causing
accumulation of metabolic intermediates such as fumarate and malate. Fumarate
reacts with available cysteines to form succinated proteins. Hence, increases in
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the NADH/NAD+ ratio appear to be a critical component contributing to elevated
2SC levels. (Frizzell et al. 2012)
Protein succination is increased on ~40 proteins in adipocytes in vitro and
in vivo has been demonstrated to decrease the functionality of some of these
proteins (Frizzell et al. 2009). Under diabetic conditions adiponectin is succinated
and subsequently has impaired ability to oligomerize, preventing its secretion
(Frizzell et al. 2009). This is significant given that high molecular weight forms of
adiponectin are decreased in the plasma of T2DM patients and animal models
(Pajvani et al. 2004). Additionally, an important mitochondrial enzyme,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), is irreversibly succinated
under diabetic conditions (Blatnik et al. 2008). Succination has also been shown
to target metabolic proteins in cancerous conditions such as aconitase, resulting
in enzymatic inhibition (Ternette et al. 2013). While we have identified many
succinated proteins and examined how succination may affect protein structure
or function, we have yet to examine how succinated proteins can be turned over
within the adipocyte.
Succination appears to be unique to white adipose tissue. Using tissue
samples from db/db and ob/ob diabetic mice we observed that succination
increased in white adipose tissue but not in other tissues. Additionally, we did not
observe an increase in succination in the presence of diet induced obesity and
insulin resistance where mice were not diabetic yet. We concluded that
succination is only markedly elevated after the onset of T2DM, not just a result of
obesity and insulin resistance. Hence, 2SC may be a marker of the progression
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to diabetes. We have confirmed that the limited oxidative demands of white
adipose tissue make it uniquely susceptible to the accumulation of succinated
proteins. (Frizzell et al. 2012, Thomas et al. 2012)
1.4. Mechanisms of Protein Turnover
Damaged proteins are removed from the cell via one of two catabolic
pathways: the ubiquitin proteasome system (UPS) or the lysosomal degradation
system known as autophagy. Protein degradation is highly regulated and occurs
in response to cellular stress, such as nutrient deprivation, to provide the cell with
amino acids, such as alanine, that can be used for gluconeogenesis. In a healthy
cell these processes maintain levels of damaged and dysfunctional proteins
below a specific threshold.
The UPS is a process of degrading damaged proteins (Figure 1.3).
Ubiquitin ligases E1, E2, and E3 will activate, conjugate, and then transfer
ubiquitin to the unfolded or misfolded proteins. Once proteins are
polyubiquitinated, i.e. have received multiple ubiquitin tags, they are targeted to
the 26S proteasome. Ubiquitinated proteins are then degraded in an ATPdependent manner by the proteasome. The resulting amino acids are then
reutilized by the cell for energy or the synthesis of new proteins.
Autophagy is the process by which damaged proteins and organelles are
degraded in the lysosome (Figure 1.4). Similar to the UPS, protein flux through
autophagy occurs to ameliorate cellular stress induced by an accumulation of
cellular debris. Autophagy induction usually occurs through the signaling cascade
involving serine/threonine-protein kinase ULK1. Autophagy begins when the
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autophagosome membrane encases the proteins and organelles to be degraded.
Numerous autophagy related genes (Atg) are involved in the stages of
membrane elongation and maturation. A critical component of autophagosome
formation—and hence a commonly used marker of autophagy—is microtubuleassociated protein light chain 3 (LC3) (Geisler et al. 2010). LC3 in the cytosol is
present as LC3-I which is activated through lipidation with the assistance of Atg7,
a 78 kDa protein containing 20 cysteine residues, to form LC3-II (Tanida et al.
2008, Glick et al. 2010, Weidberg et al. 2011). Active LC3-II formation is a
necessary component of autophagosome membrane formation. Once the
autophagosome has enclosed the proteins and organelles to be degraded, it
fuses with the acidic lysosome and dispels its contents within the
autophagolysosome (Klionsky et al. 2014, Qiao et al. 2015). Ultimately, cellular
metabolites recovered from lysosomal degradation will be reutilized in the cell for
energy or in protein synthesis. The process of autophagy is important for
maintaining healthy organelle flux. If a cell is unable to properly regulate protein
turnover and degradation under metabolically stressful conditions, it will undergo
apoptosis (Jin, 2006, Mazure and Pouyssegur, 2010).
1.5. Experimental Aims
The purpose of this investigation is two-fold: (1) to examine the efficiency
of autophagy in high glucose conditions and to determine if the autophagy
regulator Atg7 is succinated; and (2) to determine the flux through autophagy of
succinated proteins in several enriched organelle fractions in adipocytes. We
hypothesized that succinated protein turnover by autophagy might be reduced in

7

diabetic conditions and that mitochondrial enriched fractions might have more
succinated protein degradation through autophagy than other cellular fractions.
In order to mechanistically examine how succinated proteins are turned
over in the adipocyte we will use the 3T3-L1 fibroblast model. They are a preadipogenic fibroblast cell line (Green and Kehinde, 1975) that can be
differentiated and matured to adipocytes in the presence of insulin,
dexamethasone, and 3-isobutylmethylxanthine. I will maintain matured
adipocytes in 5 mM glucose to represent normoglycemic conditions or 30 mM
glucose to represent poorly controlled diabetes. In order to enhance fumarate
levels and succination in the 3T3-L1 adipocytes I have also employed a lentiviral
strategy to knockdown fumarase using a shRNA (Chapter 2).
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Figure 1.1. Mechanism of Protein Succination. Protein succination occurs by
the reaction of the tricarboxylic acid cycle metabolic intermediate fumarate with
the cysteine residue of a protein. This irreversible bond formation produces S-2succinocysteine (2SC).
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Figure 1.2. Mitochondrial Stress Leads to Protein Succination. Glucotoxicity
will induce cellular stress that results in elevated protein succination. Nutrient
excess (glucotoxicity) will increase the ATP/ADP ratio resulting in an elevated
mitochondrial membrane potential (∆Ψm), increased NADH levels, and
subsequently the accumulation of the tricarboxylic acid cycle intermediate
fumarate. Fumarate will then react with protein thiol groups to form a succinated
protein (Protein-2SC).
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Figure 1.3. Degradation of Proteins in the Proteasome. Proteasomal protein
degradation occurs when proteins become polyubiquitinated, targeting them to
the 26S proteasome to be degraded into metabolites.
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Figure 1.4. Degradation of Proteins by Autophagy. Autophagy is the
lysosomal degradation of proteins and organelles. The conversion of the initial
phagophore to the autophagosome occurs with the assistance of multiple
autophagy related genes (Atgs) and active microtubule-associated protein light
chain 3 (LC3 in the form of LC3-II) to enclose the autophagosome. The
autophagosome will then fuse with the acidic lysosome where its contents will be
degraded and recycled by the cell.
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Chapter II
AUTOPHAGIC FLUX IN ADIPOCYTES DURING DIABETES
2.1. Introduction
Succination is an irreversible protein modification from the reaction of
fumarate with cysteine to produce 2SC (Figure 1.1). When 3T3-L1 adipocytes
are matured in high glucose (30 mM, diabetic conditions) for 8 days, they will
accumulate succinated proteins to a greater extent than adipocytes matured in
normal glucose (5 mM, non-diabetic conditions), as detected using a specific
anti-2SC antibody (Nagai 2007; Frizzell 2009, 2012). However, if the adipocytes
are removed from a high glucose environment for several days, succinated
proteins are turned over and do not accumulate further (Frizzell et al. 2012;
Figure 2.1, lanes 4-6 versus lanes 7-9). This suggests that when adipocytes are
switched back to 5 mM glucose for a few days they can be rescued from the high
glucose insult.
Previous research in our laboratory has further investigated the
pathways mediating succinated protein turnover by inhibiting the proteasome
with MG132 (carbobenzoxyl-L-leucyl-L-leucyl-L-leucinal) or inhibiting autophagy
with chloroquine (CQ, drug increases lysosomal pH). These treatments were
added to the growth medium of adipocytes during the last 4 days of maturation
when cells were switched from high to normal glucose conditions. The turnover
of succinated proteins in normal glucose was unaffected by MG132 treatment,
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suggesting that the proteasome did not play a major role in succinated protein
turnover (unpublished data). In contrast, when adipocytes transitioning from high
glucose to normal glucose were simultaneously treated with CQ the succinated
proteins appeared to accumulate (unpublished data, Figure 2.1, lanes 7-9 versus
lanes 10-12). These results suggest succinated protein turnover occurs through
autophagy in the adipocyte.
A parallel investigation of specific succinated proteins in adipocytes
matured in high glucose has revealed that Cathepsin B, an important lysosomal
protease, can be modified by 2SC. Cathepsin B is succinated on Cys108 of the
occluding loop that facilitates its peptidylpepdidase activity (Illy et al. 1997,
Merkley et al. 2014). We hypothesized that succination of Cys108 might
contribute to reduced Cathepsin B activity and we have since demonstrated that
Cathepsin B activity is reduced in high glucose conditions. In addition, this
reduction can be partially recovered when adipocytes are switched to a normal
glucose environment (unpublished data). Therefore, it is possible that a reduction
in lysosomal protease activity as a result of Cathepsin B succination contributes
to the accumulation of succination in 30 mM glucose conditions, and why
succinated protein turnover is enhanced when cells are switched back to 5 mM
glucose conditions.
While we understand that succinated proteins can be turned over when
switched from high glucose back to normal glucose and that this occurs by
autophagy over several days, we have not yet investigated the basal rates of
autophagic flux in 3T3-L1 adipocytes in normal versus high glucose. This is
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important as we have demonstrated that the activity of at least one lysosomal
protease is decreased in high glucose. In addition, I would like to investigate
another important regulator of autophagic flux, the autophagy protein ubiquitinlike modifier-activating enzyme Atg7. Atg7 is essential for the lipidation, i.e.
activation, of LC3, a protein that functions in autophagosome membrane
formation (Figure 1.4). Atg7 is of interest because the active site contains a
cysteine residue (Cys567), therefore succination of this site on Atg7 may reduce
enzymatic efficiency and impair the autophagic process.
Subsequently, I investigated (1) the profile of succinated proteins after 24
hours of 25 µM CQ administration, (2) the rate of flux through autophagy in 5 mM
and 30 mM glucose conditions, and (3) Atg7 levels and its succination. I
hypothesized that the rate of autophagic flux may be lower in adipocytes cultured
in 30 mM glucose versus 5 mM glucose, and that Atg7 may be more succinated
in cells matured in high glucose conditions.
2.2. Results
In line with our previous observations (Frizzell et al. 2012), protein
succination in 3T3-L1 adipocytes is increased in high (30 mM) versus normal (5
mM) glucose conditions (Figure 2.2, lanes 1-3 versus lanes 4-6). I observed
consistent levels of succination with and without CQ treatment in both 5 mM and
30 mM adipocytes (Figure 2.2, 2SC panel lanes 4-6 versus lanes 7-9 and lanes
1-3 versus 10-12). The lack of marked 2SC accumulation following 24 hours of
CQ treatment is not surprising since our unpublished observations demonstrate
that succinated proteins are turned over slowly, accumulating in the cell after 4
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days of CQ treatment (Figure 2.1). While CQ did not markedly alter the
accumulation of succinated proteins, an investigation of autophagic flux at this
time point is necessary to assess the basal rate of autophagy. LC3-II levels are
normally below the threshold for detection in 5 mM or 30 mM glucose conditions.
However, when the cells are treated with 25 µM CQ for 24 hours to inhibit
autophagy, LC3-II accumulates and autophagic flux can be determined by
subtracting LC3-II levels in the presence of CQ from LC3-II levels in the absence
of CQ. I observed that LC3-II accumulates in 30 mM glucose conditions and to a
greater extent in 5 mM glucose conditions (Figure 2.3, LC3 panel). Therefore,
these data demonstrate that basal flux through autophagy is decreased in
adipocytes matured in 30 mM glucose versus 5 mM glucose (Figure 2.3, graph).
The autophagy regulating protein Atg7 is essential for the conversion of
LC3 to its active form LC3-II. An initial examination of total protein levels of Atg7
suggests that Atg7 levels are reduced in adipocytes matured in 30 mM glucose
versus 5 mM glucose (Figure 2.4), potentially related to the decreased lipidation
of LC3 and reduced autophagic flux in 30 mM glucose conditions. In addition to
this decrease, we also determined if modification of Atg7 by 2SC was occurring,
potentially impairing its enzymatic activity. Enrichment of Atg7 from adipocyte
whole cell lysates matured in 5 mM or 30 mM glucose by immunoprecipitation
was performed. The enrichment of Atg7 was successful, as confirmed by
immunoblotting with Atg7 (Figure 2.5, Atg7 panel), however, immunoblotting was
unable to reliably determine if this protein is succinated as variable results were
obtained, a representative image is shown (Figure 2.5, 2SC panel).
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2.3. Discussion
Succinated proteins are elevated in adipocytes matured in high glucose
conditions (Frizzell et al. 2012). Our results demonstrated that basal autophagic
flux is reduced in cells cultured in 30 mM glucose versus those in 5 mM glucose
(Figure 2.3). This inhibition of flux did not result in further accumulation of
succinated proteins (Figure 2.2). We have previously illustrated that succinated
protein turnover occurs slowly over several (~4) days in the presence of CQ
(Figure 2.1). Therefore, these data combined with the reduced flux observation
confirm that the turnover of succinated proteins is reduced in adipocytes under
diabetic conditions. One possible explanation for this reduction is the succination
of Cathepsin B. As described, Cathepsin B is succinated on an important
cysteine residue in high glucose conditions and its enzymatic activity is reduced
(Illy et al. 1997, Merkley et al. 2014, and unpublished data). It is possible that
succination of additional metabolic enzymes occurs as well and contributes to a
reduction in autophagic flux under high glucose stress.
Considering that LC3-II levels were lower in adipocytes matured in high
glucose, we examined Atg7, the cysteine rich enzyme mediating LC3-II lipidation.
Our initial immunoblotting of total levels of Atg7 provides evidence that this
critical protein involved in autophagy may have reduced expression in high
glucose conditions (Figure 2.3). I proposed that succination of this protein may
occur on Cys567 in the active site, potentially reducing its enzymatic efficiency.
In this study we were not able to conclusively determine if this protein could be
succinated; this will be an area of continuing investigation in the laboratory. While
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these data may have provided additional information on the source of reduced
LC3-II, the study still suggests that Atg7 levels are lower in high glucose.
The accumulation of succinated proteins in high glucose conditions is
representative of the metabolic stress induced by a diabetic state. Collective
insults to the adipocyte during diabetes such as impaired autophagic flux (as
described above), succinated protein accumulation, and oxidative stress all
contribute to metabolic dysfunction. Additional evidence suggests that under
diabetic conditions autophagic flux is reduced (Soussi et al. 2015). This recent
study described a measurable decrease in autophagic flux of ob/ob (obese)
mouse tissue verses ob/+ controls. They also relate reduced autophagic flux in
3T3-L1 adipocytes to decreased mRNA expression of death associated protein
kinase 2 (DAPK2), a protein proposed to modulate autophagic flux but needing
further investigation. Additionally, they propose autophagic flux in human diabetic
adipose tissue is reduced, providing evidence that dysregulation of flux through
autophagy under a high glucose insult should be clinically investigated. A lack of
sufficient protein turnover as well as impairment of succinated protein turnover
may further interfere with the process of adipose tissue expansion, a normal
result of nutrient excess. These forms of amplified cellular stress in high glucose
foster an unhealthy environment for adipocyte expansion and subsequently may
lead to cellular death. Therefore, succination is a characteristic marker of this
metabolic dysregulation.
Since the turnover of damaged proteins is important for the health of the
adipocyte, accumulation of succinated or oxidatively modified proteins in high
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glucose conditions appears to contribute to adipocyte dysfunction. The metabolic
stress induced by damaged protein accumulation is a potential source of adipose
tissue inflammation. Inflammation in the adipose tissue has been linked to
hypoxia (Halberg et al. 2009, Sun et al. 2013). Hypoxia has been noted as an
early initiator of adipose tissue dysfunction since it is indicative of adipose tissue
expansion that outpaces the growth of vasculature (Halberg et al. 2009).
Additionally, hypoxia inducible factor 1 alpha (HIF-1α), a common marker of
hypoxia, is decreased after weight loss (Cancello et al. 2005). In addition to high
glucose stress, other factors may contribute to obesity-induced inflammation and
reduced autophagic flux such as glycogen accumulation (Ceperuelo-Mallafré et
al. 2016; Singh and Singh, 2015).
Overall my results suggest that autophagic flux is decreased in
adipocytes under high glucose stress. This decrease may be a result of
increased succination of components of the autophagic machinery and may in
part explain the inability of the adipocyte to adapt to metabolic stress during
diabetes.
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Figure 2.1. Mechanism of Succinated Protein Turnover. Succinated protein
turnover occurs by autophagy. Adipocytes were matured in 5 mM or 30 mM
glucose for 8 days. A subset of adipocytes were matured in 30 mM glucose for 4
days and then switched to 5 mM glucose for the remaining 4 days of maturation
(30→5) and treated with or without 25 µM chloroquine. Protein 40 µg was
separated by 1-D PAGE and detection of protein succination was performed
using a polyclonal anti-2SC antibody (2SC panel). MW markers are shown in
kDa and β-Tubulin is shown to demonstrate equal protein loading.
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Figure 2.2. Succinated Protein Turnover by Autophagy. Adipocytes matured
in 5 mM or 30 mM glucose with and without 25 µM CQ for 24 hours were
assessed for succination (2SC panel). Total cell lysates, 30 µg protein per lane,
were separated by 1-D SDS PAGE (n=3 per group). Molecular weight markers
(kDa) are indicated on left.
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Figure 2.3. Flux through Autophagy in 3T3-L1 Adipocytes. Flux through
autophagy in adipocytes grown in 5 mM or 30 mM glucose as measured by LC3II accumulation in the presence of CQ. LC3-II levels accumulate in the presence
of CQ to a greater extent in 5 mM than 30 mM glucose conditions (LC3 panel).
The rate of flux through autophagy is reduced in 30 mM glucose conditions
compared to 5 mM glucose, as determined by the densitometric subtraction of
LC3-II (-CQ) from LC3-II (+CQ) (Graph). Representative immunoblot using 10 µg
of total cell lysate protein per lane (n=3 per group). Molecular weight markers
(kDa) are indicated on left.
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Figure 2.4. Atg7 Protein Levels. Total levels of Atg7 in adipocytes matured in 5
mM or 30 mM glucose. The levels of Atg7 are decreased in 30 mM glucose
compared to 5 mM (Atg7 panel). Total cell lysates, 30 µg protein per lane, were
separated by 1-D SDS PAGE (n=3 per group). Molecular weight marker of 75
kDa indicated on left.
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Figure 2.5. Immunoprecipitation of Atg7. Immunoprecipitation of Atg7 (antiAtg7, Cell Signaling) from adipocytes matured in 5 mM or 30 mM glucose.
Immunoprecipitation was successful in enriching relatively equal amounts of Atg7
protein from all samples (Atg7 panel). The blot was stripped and re-probed with
anti-2SC. No detection of succination in these Atg7 precipitates (2SC panel).
Immunoprecipitated protein samples were separated by 1-D SDS PAGE (n=3 per
group). Molecular weight marker of 75 kDa indicated on left.
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Chapter III
AUTOPHAGIC FLUX IN ADIPOCYTES FOLLOWING FUMARASE
KNOCKDOWN
3.1. Introduction
Fumarase (FH) deficiency predisposes an individual for hereditary
leiomyomatosis and renal cell cancers (HLRCC) (Pollard et al. 2005). Bi-allelic
FH mutation, i.e. loss of the second copy of the FH gene, increases fumarate
levels locally and is associated specifically with aggressive renal cell carcinomas
(Pollard et al. 2005). Protein succination occurs when fumarate reacts with
cysteine residues and results in the formation of 2SC (Alderson et al. 2006). This
modification can be detected using immunohistochemistry with the anti-2SC
antibody (Nagai et al. 2007). Since elevated levels of fumarate will increase
protein succination, the detection of 2SC is a useful biomarker in the assessment
of these FH deficient cancers (Bardella et al. 2011, Castro-Vega et al. 2014,
Ternette et al. 2013, Zheng et al. 2015). Furthering our understanding of the
specific metabolite and consequent protein changes induced by this fumarate
accumulation may give rise to novel clinical interventions that target FH-deficient
renal cell carcinomas.
Our laboratory has previously investigated a model of maximal succination
using murine embryonic fibroblasts (MEFs) derived from mice with Fh gene
knocked out (Ashrafian et al. 2010). Analysis of the cell lysate fractions
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demonstrated an accumulation of succinated proteins in the total cell
homogenate, but by comparison mitochondrial enriched fractions appeared to
have less succination (unpublished data, Figure 3.1, lanes 1-3 versus lanes 7-9).
Considering fumarate is produced and accumulates in the mitochondria, this
observation was surprising. Further investigation of these Fh-deficient MEFs with
the autophagy inhibitor chloroquine (CQ) revealed that the mitochondria did
contain succinated proteins but these were rapidly turned over by autophagy
(Figure 3.1, lanes 7-9 versus lanes 10-12). These data are of interest but since
these are immortalized cancer cells, they may have altered autophagic flux.
Since our previous observations on autophagy in adipocytes in high glucose
were in 3T3-L1 cells (Chapter 2), we also wanted to prepare 3T3-L1 adipocytes
with fumarase shRNA knockdown (Fh k/d) to better understand the role of
autophagy in succinated protein turnover within enriched cellular fractions. I will
utilize Fh k/d adipocytes to assess if the metabolic alterations present in
immortalized cells are synonymous with those present in adipocytes.
To generate an adipocyte model of enhanced succination, 3T3-L1
fibroblasts were transduced with a lentiviral vector containing either fumarase
shRNA or a scrambled control vector. The cells that successfully incorporated
the vector were selected using the puromycin resistance gene that had been
incorporated in the vector; and the surviving cells were further propagated in the
presence of puromycin until confluent. The fibroblasts were then differentiated
and matured to adipocytes according to the normal procedure. These 3T3-L1
adipocytes have reduced Fh protein levels but not complete knockout like the
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immortalized MEF cells. Our laboratory has demonstrated that the accumulation
of fumarate following Fh k/d results in increased succination of proteins when
matured in normal (5 mM) glucose conditions (unpublished data). Subsequently
succination increases independent of high glucose derived metabolic changes.
The current experiment will likewise utilize Fh k/d adipocytes matured in 5 mM
glucose to investigate succination and autophagy.
To evaluate compartment specific alterations in succination and
autophagy, I will administer 25µM CQ 24 hours before harvesting cells. I will
investigate the accumulation of succinated proteins in the total homogenate and
enriched fractions of cytosolic, mitochondrial, and nuclear proteins. Following this
I will evaluate the rate of autophagic flux both in total homogenate and
mitochondrial fractions. I hypothesize succinated proteins will accumulate in the
mitochondria of Fh k/d adipocytes compared to scrambled controls. As described
previously, autophagic flux represents the amount of lysosomal degradation of
proteins within the cell lysates and is measured by the accumulation of LC3-II in
the presence of CQ. We previously observed that cells matured in high glucose
have reduced autophagic flux compared to those matured in normal glucose
(Chapter 2). Therefore, I propose that flux through autophagy will be altered in Fh
k/d cells compared to their respective scrambled controls.
3.2. Results
Cells with Fh k/d have markedly more succination than those treated with
a scrambled control virus (Figure 3.2, 2SC panel, lanes 1-6 versus 7-12). These
total cell homogenates had no apparent change in protein succination upon
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addition of CQ, though there was a slight increase in succination band density.
Total cell lysates were then evaluated for Fh levels to demonstrate that the
knockdown was efficient (Figure 3.2, Fumarase panel, lanes 1-6 versus 7-12).
Next, the flux through autophagy was assessed by comparing adipocytes with
and without CQ administration. The accumulation of LC3-II as a result of
autophagic inhibition by CQ is a reliable measure of autophagic flux. These data
demonstrate a trend for a decrease in autophagic flux in Fh k/d cells compared to
scrambled controls (Figure 3.2, LC3 panel, lanes 4-6 minus 1-3 versus lanes 1012 minus 7-9 and graph of densitometric analysis). We previously showed that
autophagic flux is reduced in adipocytes matured in high glucose compared to
normal glucose (Figure 2.2). It appears that Fh-deficient adipocytes also have
reduced autophagic flux compared to scrambled controls.
The cellular protein profile was then assessed for compartment specific
differences in protein succination and autophagic flux by generating fractions
enriched in cellular organelles. Fractionation was assessed using markers for
mitochondria, cytosol, and nucleus to demonstrate enrichment of those
compartments (Figure 3.3, voltage dependent anion channel 2 [Vdac2], α-tubulin,
and histone H3 panels respectively). High levels of succination are evident in the
cytosolic, mitochondrial, and nuclear compartments (Figure 3.3, 2SC panel,
lanes 1-6 compared to 7-12 compared to 13-18), but only the mitochondrial
compartment demonstrates increased succinated protein levels following
treatment with CQ (Figure 3.3, 2SC panel, lanes 7-9 versus 10-12). This
increased accumulation of succinated proteins when autophagy was inhibited
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indicates these proteins were turnover by autophagy in the mitochondria at a
faster rate than the two other fractions. These data suggest that mitochondria
accumulate and turn over proteins at a faster rate. These observations align with
previous data in Fh deficient MEF cultures (unpublished data, Figure 3.1). We
additionally evaluated the levels of Atg7 and observed that it was present
predominantly in the cytosolic fraction (Figure 3.3, Atg7 panel lines 1-6), possibly
because Atg7 accumulates with CQ administration in this cytosolic fraction
(Figure 3.3, Atg7 panel, lines 4-6 versus 1-3).
To increase our understanding of the unique accumulation occurring in
the mitochondrial enriched fraction, we further evaluated the Fh k/d lysates and
compared them to scrambled control mitochondrial enriched fractions. We
confirmed that Fh k/d lysates have markedly elevated succination compared to
scrambled control (Figure 3.4, 2SC panel, lanes 7-12 versus 1-6). Additionally,
the results clearly confirmed that mitochondrial enriched fractions accumulate
more succinated proteins in the presence of CQ, demonstrating that these
fractions contain more succinated proteins that are normally turned over more
rapidly by autophagy (Figure 3.4, 2SC panel, lanes 10-12 versus 7-9). Despite
this, assessment of flux through autophagy by evaluating mitochondrial LC3-II
levels as above indicates that that there is a trend for a decreased rate of overall
flux in Fh k/d cells compared to scrambled controls (Figure 3.5).
Succinated protein accumulation occurs in the Fh k/d model due to the
accumulation of fumarate. I speculated that cells with reduced fumarase levels
might accumulate other protein modifications such as succinylation which occurs
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when succinyl-CoA, a derivative of a Krebs cycle intermediate, reacts with
protein lysine residues. Increased back pressure on the Krebs cycle may permit
succinyl-CoA accumulation and hence elevate levels of succinylation. We have
previously demonstrated that there are no significant increases in succinylation in
high glucose conditions compared to normal glucose (Manuel and Frizzell, 2013).
The Fh k/d model likewise demonstrates succinylated-lysine is unchanged in
scrambled control versus Fh k/d adipocytes and unchanged by the inhibition of
autophagy with CQ (Figure 3.6, Succinyl-K panel). This indicates succinylated
proteins do not accumulate in this model of reduced Krebs cycle flux and
suggests they are not turned over by autophagy in the way that succinated
proteins are.
3.3. Discussion
Fumarate accumulation due to a reduction in the tricarboxylic acid cycle
enzyme fumarase leads to an increase in protein succination. We hypothesized
that flux through autophagy might be altered as a result of Fh k/d. Our
investigation demonstrated that there is a trend for a decrease in autophagic flux
in the total homogenate of Fh k/d cells compared to scrambled controls (Figure
3.2). This trend is consistent with the reduced autophagic flux in high glucose
conditions compared to normal glucose (Figure 2.2), suggesting that increased
succination plays a role in decreasing normal levels of autophagic flux. Both
these studies investigated 3T3-L1 adipocytes, but the Fh k/d cells may have
alternative mechanisms of maintaining autophagic flux. As discussed in Chapter
2, Cathepsin B has been shown by mass spectrometry to be succinated in high
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glucose conditions but not in normal glucose (unpublished data). This succination
results in a decrease in Cathepsin B activity in high glucose treated adipocytes.
While we speculated that Fh k/d adipocytes would also have reduced Cathepsin
B activity, a preliminary investigation suggests that Cathepsin B activity is not
reduced in Fh k/d cells despite their elevation in succinated protein levels
compared to scrambled controls (unpublished data). A potential explanation for
these enzymatic differences is that Fh k/d adipocytes increase Cathepsin B
protein levels to compensate for reduced activity as a result of succination.
Alternatively, the Fh k/d adipocytes may depend more on the activity of other
cathepsin enzymes (e.g. Cathepsin D) even if Cathepsin B were also succinated
in this model, perhaps on a cysteine reside that is non-essential for activity. Since
the Fh k/d adipocytes have elevated succination compared to high glucose
adipocytes, Fh k/d may also induce more pronounced metabolic adaptations due
to elevated cellular stress as a result of succination.
Since mitochondria are the location of fumarate production, we predicted
that succinated proteins would accumulate in the mitochondria of adipocytes. We
previously demonstrated that succinated protein content was low in the
mitochondria but accumulated in the presence of CQ in MEFs with Fh knock out
(Figure 3.1). This indicates that succinated proteins in the mitochondrial rich
fraction were turned over by autophagy. We then generated a 3T3-L1 adipocyte
model of elevated succination by reducing Fh levels to investigate cellular
fractions in a non-cancerous cell line. As anticipated, succinated proteins
accumulate in the cytosolic and nuclear enriched fractions independent of CQ
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administration (Figure 3.4, 2SC panel, lanes 1-6 and lanes 15-20). Additionally,
Fh k/d adipocytes accumulate succinated proteins in the mitochondrial enriched
fraction only in the presence of CQ as did the MEF cells (Figures 3.1 and 3.4).
This heightened accumulation might be expected since mitochondria are the site
of fumarate production. The rapid turnover in the mitochondria may mitigate
mitochondrial damage and compensate for localized fumarate concentrations
being high. Future experiments should delineate the role of the mitochondria
further by investigating specific autophagy of the mitochondria, i.e. mitophagy
(Lemasters, 2005, Kissova et al. 2004). Additionally, flux through autophagy is
reduced in Fh k/d mitochondrial preparations compared to scrambled controls
(Figure 3.5). Impairment of proper protein recycling through the lysosome leads
to an accumulation of damaged cellular debris and may contribute to
inflammation as described previously (Chapter 2). Our current results highlight
that succinated proteins are turned over by autophagy in the mitochondrial
enriched fraction of Fh k/d adipocytes, but it will be important to ensure that
future fraction preparations are more organelle specific, separating mitochondria
from any lysosomes or endoplasmic reticulum that may contaminate this fraction.
Levels of succinylation were not different in scrambled control and Fh k/d
adipocytes (Figure 3.6, Succinyl-K panel, lanes 1-5 verses lanes 6-10). SuccinylK was also unaltered when adipocytes were treated with the autophagy inhibitor
CQ (Figure 2.6, Succinyl-K, lanes 1-2 verses 3-5 and lanes 6-8 verses 9-10). The
lack succinylated protein accumulation in adipocytes is not surprising since
succinyl-CoA levels are normally low in the mitochondria. Most work
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documenting an increase has been observed in sirtuin (SIRT) 5 knockout models
since SIRT 5 has been described as a desuccinylase (Park et al. 2013, Zhang et
al. 2015). Succinyl-CoA levels may not accumulate even if the Krebs cycle was
inhibited as long as the cells have a demand to produce GTP, favoring the
hydrolysis of this this thioester. If succinylation accumulated it would have been
interesting to determine if these modified proteins were turned over by autophagy
similar to succinated proteins (in addition to the known turnover by SIRT 5). The
lack of net change in succinylation in either cell type in the presence of CQ
confirms that Fh k/d adipocytes uniquely increase succination without
accumulating other acyl CoA derived protein modifications.
We conclude that reducing the levels of Fh in adipocytes using shRNA
will increase succination and reduce flux through autophagy. As in the cell culture
diabetic model, adipocytes with Fh k/d have an accumulation of LC3-II in the
presence of CQ indicating a reduction in autophagic flux. The turnover of
succinated proteins by autophagy is most pronounced in mitochondrial enriched
fractions likely because the mitochondria are the site of the tricarboxylic acid
cycle where fumarate is produced. This model may have utility for more specific
investigations of succinated protein turnover in the mitochondria to examine
mitophagy, i.e. autophagy of the mitochondria.
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Figure 3.1. Succinated Protein Turnover in MEF Mitochondria. Murine
embryonic fibroblasts (MEFs) from fumarase knockout mice treated with 25 µM
chloroquine (CQ) for 18 hours to inhibit autophagy. Lysates were fractionated
then assessed for protein succination. Total cell lysates have consistent levels of
protein succination with and without CQ administration (2SC left panel).
Mitochondrial enriched fractions have markedly increased succination in the
presence of CQ (2SC right panel). Cellular fractions were separated by 1-D
SDS PAGE (n=3 per group, 30 µg protein per lane). Molecular weight markers
(kDa) are indicated on left.
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Figure 3.2. Fh k/d Protein Succination and Autophagic Flux. Adipocytes were
transduced with scrambled control (scram) or fumarase knockdown (Fh k/d)
shRNA and matured in 5 mM glucose conditions following selection with
puromycin. Succination of proteins is markedly increased in Fh k/d cells
compared to scram cells (2SC panel). Fumarase levels are reduced in the Fh k/d
cells compared to the scram cells, confirming an effective reduction in fumarase
levels (Fumarase panel). LC3-II accumulates in the presence of 25 µM CQ in
both scram and Fh k/d samples (LC3 panel). GAPDH levels are indicated as a
loading control (GAPDH panel). Flux through autophagy is quantified as the
increase in LC3-II levels after CQ administration as determined by the
densitometry (Graph). Total cell lysates, 30 µg protein per lane, were separated
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by 1-D SDS PAGE (n=3 per group). Molecular weight markers (kDa) are
indicated on left.
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Figure 3.3. Fh k/d Protein Succination in Enriched Fractions. Cytosolic,
Mitochondrial (Mito.), and Nuclear enriched fractions of fumarase knockdown (Fh
k/d) adipocytes grown in 5 mM glucose with and without 25 µM CQ for 24 hours.
Elevated levels of protein succination are present in all Fh k/d fractions. 2SC is
increased markedly in the mitochondrial enriched fraction with CQ administration
(2SC panel). Atg7 levels in the cytosolic fraction are increased in the presence of
CQ (Atg7 panel). Vdac2 is indicated to demonstrate enrichment of mitochondrial
fractions (Vdac2 panel). Tubulin is shown indicate total loading between groups
(α-tubulin panel). Histone H3 is indicated to demonstrate enrichment of nuclear
fractions (Histone H3 panel). Total cell lysates, 30 µg protein per lane, were
separated by 1-D SDS PAGE (n=3 per group). Molecular weight markers (kDa)
are indicated on left.
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Figure 3.4. Fh k/d Protein Succination in Mitochondria. Mitochondrial
enriched fractions of scrambled control (scram) and fumarase knockdown (Fh
k/d) adipocyte samples with and without 25 µM CQ administration. Succination of
proteins is present in the Fh k/d cells and increased in the presence of CQ (2SC
panel). Reduced fumarase levels in the Fh k/d samples confirming the
effectiveness of the shRNA knockdown (Fumarase panel). Citrate Synthase is
shown as a mitochondrial loading control (CS panel). Total cell lysates, 30 µg
protein per lane, were separated by 1-D SDS PAGE (n=3 per group). Molecular
weight markers (kDa) are indicated on left.
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Figure 3.5. Fh k/d Autophagic Flux in Mitochondria. Mitochondrial enriched
fractions of scrambled control (scram) and fumarase knockdown (Fh k/d)
adipocyte samples with and without 25 µM CQ for 24 hours. LC3-II accumulation
after CQ administration is a measure of autophagic flux (LC3 panel).
Quantification of autophagic flux indicates a trend for a decreased flux in
adipocytes that have Fh k/d (Graph). Total cell lysates, 10 µg protein per lane,
were separated by 1-D SDS PAGE (n=3 per group). Molecular weight markers
(kDa) are indicated on left.
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Figure 3.6. Succinylation in Fh k/d and Scrambled Control Adipocytes.
Evaluation of protein modification by succinyl-CoA in fumarase knockdown (Fh
k/d) adipocyte samples with and without 25 µM CQ administration. Succinylated
lysine was assessed in total homogenate of scrambled control and Fh k/d
samples. Protein modification by succinyl-CoA is not altered by CQ
administration (Succinyl-K panel, n=2 or 3 per group). Total cell lysates, 30 µg
protein per lane, were separated by 1-D SDS PAGE.
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Chapter IV
FUTURE DIRECTIONS
These results highlight the importance of understanding adipocyte
metabolism in context with protein succination and autophagy. The reduction in
autophagic flux, as measured by LC3-II accumulation, resulting from high
glucose induced cellular stress is a representation of metabolic dysregulation in
diabetic conditions. Further investigation of autophagy in the context of diabetes
should assess adipocytes extracted from the adipose tissue of db/db (diabetic)
mice or similar models. Linking diabetes-induced elevations in 2SC to reductions
in autophagic flux would further support the utility of protein succination as a
marker of metabolic stress under a high glucose insult.
Continued investigation of the crucial autophagic protein Atg7 and the
cathepsin proteins will help divulge the precise mechanism of autophagy
inhibition under high glucose conditions. Delineating the succination state of Atg7
in high glucose conditions and assessing if its succination contributes to reduced
autophagic flux. Since we know Cathepsin B is specifically succinated in high
glucose when autophagic flux is reduced and that its activity levels are unaltered
in Fh k/d adipocytes, further work should evaluate if Cathepsin B is succinated in
the Fh k/d model. Additionally, measuring total protein levels of the major
cathepsin proteins could assess for compensatory functions when Cathepsin B
activity is reduced.
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The 3T3-L1 adipocyte model of diabetes will continue to uncover
metabolic pathways contributing to high glucose induced metabolic stress. An
evaluation of succination and autophagic flux in cellular fractions of high glucose
adipocytes can be used to understand the importance of the mitochondria in
succinated protein turnover. In particular, preparation of cellular fractions that
specifically separate the mitochondria from lysosomes and other organelles
would ensure that 2SC accumulation in the mitochondrial enriched fraction is not
due to accumulation within the lysosome in the presence of CQ. These
investigations could ultimately be expanded to adipose tissue from diabetic
patients to elucidate the connection between autophagic flux and accumulation of
2SC. As research on diabetes and protein succination progresses, it is
increasingly evident that 2SC is a valuable marker of adipocyte metabolic stress.
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Chapter V
MATERIALS AND METHODS
5.1. Cell Culture
3T3-L1 murine fibroblasts were purchased from American Type Culture
Collection (Manassas, VA) and maintained up to 8 passages in DMEM
containing 5 mM glucose, 10% Bovine Calf Serum (Thermo Scientific), 1%
penicillin/streptomycin (CellGro) at 37oC with 5% CO2 and 95% humidity. Medium
was changed every 2 days. At 70-80% confluence cells were trypsinized
(Thermo Scientific), neutralized with excess medium and collected by
centrifugation at 1,000 g for 5 min at 25oC. The cells were then re-suspended in
medium for a new passage.
3T3-L1 fibroblasts were seeded at densities of 50,000 and 100,000
cells/well for 6-well plates and 10 cm2 petri dishes respectively. 3T3-L1
fibroblasts were induced to differentiate 24 hours post-confluence (~3-4 days) in
DMEM with 10% Fetal Bovine Serum (Atlanta Biologicals), 1%
penicillin/streptomycin, insulin (10 μg/mL), dexamethasone (0.3 μM), 3-isobutyl1-methylxanthine (0.5 mM) and 30 mM glucose for 3 days. At day 0,
differentiation medium was removed, cells were washed with PBS and
maturation medium containing 5 mM/0.3 nM or 30 mM/3 nM glucose/insulin was
applied. The medium was changed every 2 days and the adipocytes were
matured in 5 mM or 30 mM glucose for 8 days. When the lysosomal inhibitor was
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used, cells were treated with 25 µM chloroquine (Sigma Aldrich) at day 7 for 24
hours before collection. Cells cultured in 5 mM glucose were supplemented with
5 mM glucose daily and several hours prior to protein harvest to maintain glucose
levels.
5.2. Protein Extraction from Adipocytes
All cellular protein was collected at day 8 by lysing the cells in
radioimmunoprecipitation assay buffer (RIPA, Appendix A) and sonicated 3 times
for 12-15 seconds each. Ice cold acetone, 9 x volume, was then added to the
samples, vortexed, then allowed to sit on ice for 10 min. The samples were then
vortexed again and centrifuged at 2,800 g for 10 min at 4oC. The acetone was
decanted and the samples re-suspended in 0.5-1 mL of RIPA buffer and
sonicated 3 times for 10 seconds each. The protein concentration was
determined using the Lowry assay (Appendix B).
5.3. Lentiviral Vector Production
The lentiviral vectors were prepared by the University of South Carolina
Viral Vector Facility. Briefly, TRC2 Fh1 shRNA, clone- TRCN0000246831 or
SHC202 MISSION TRC2 pLKO.5-puro non-mammalian shRNA control plasmids
(Sigma/Aldrich, St. Louis, MO) were used to generate the lentiviral vectors. The
vectors also contained a puromycin resistance gene. 15 μg vector plasmid, 10 μg
psPAX2 packaging plasmid (Addgene 12260, Cambridge, MA), 5 μg pMD2.G
envelope plasmid (Addgene 12259, Cambridge, MA) and 2.5 μg pRSV-Rev
plasmid (Addgene 12253, Cambridge, MA) were transfected into 293T cells. The
filtered conditioned medium was collected and stored at -80°C until use.
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Lentiviral vectors were generated using a transient transfection protocol, as
described previously (Kantor, 2011). Briefly, 15 µg vector plasmid, 10 µg psPAX2
packaging plasmid (Addgene #12260), 5 µg pMD2.G envelope plasmid
(Addgene #12259) and 2.5 µg pRSV-Rev plasmid (Addgene #12253) were
introduced into 293T cells by transfection. Vector particles were collected in
filtered conditioned medium at 72 hour post-transfection. Vector and viral stocks
were aliquoted and stored at -80 °C.
5.4. Lentiviral Transduction
3T3-L1 fibroblasts were grown in 1 g/L glucose DMEM with 10% FCS and
1% penicillin streptomycin until 90% confluent on 10 cm2 petri dishes. The
fibroblasts were incubated overnight with 5 mL of filtered conditioned medium
containing 150 µL Fh-1 shRNA or control virus. Successfully transduced
fibroblasts were selected using 2.5 µg/mL puromycin, supplemented in the
medium every 48 hours. The selected fibroblasts were propagated until
confluent, then differentiated to adipocytes and matured for 8 days in 5 mM
glucose as described above. In some cases the adipocytes were treated with 25
µM chloroquine for 24 hours before the cells were harvested into fractions as
described below.
5.5. Cellular Fractionation
Mitochondrial enriched preparations were collected by harvesting cells in
homogenization buffer (Appendix A). The cells were washed 3 times in ice-cold
PBS prior to scraping in homogenization buffer. Each sample was homogenized
on ice with a glass homogenizer 20 times, then passed through a 25 gauge
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needle 5 times. 150 µL of total homogenate was collected in a separate tube,
and then the remaining sample volume was centrifuged at 500 g for 10 min to
generate the nuclear pellet. The supernatant was placed in a clean tube and
centrifuged at 18,000 g for 20 min to generate the mitochondrial pellet. The
resulting supernatant was then collected as the cytosolic fraction. Nuclear and
mitochondrial pellets were re-suspended in RIPA buffer; then all fractions were
processed and quantified as described above.
5.6. Western Immunoblotting
Samples were prepared using 10-30 µg protein with the addition of 4x
Laemmli reducing buffer, boiled at 95oC, pulse centrifuged, loaded on 7.5%,
12%, or 18% Tris-Glycine gel (TGX, Biorad), and electrophoresed at 200 V for 60
min at room temperature. The protein was transferred to a PVDF membrane in
transfer buffer at 250 mA for 100 min at 4 oC. The membrane was stained with
Ponceau Red, and then blocked in 5% non-fat milk or 5% bovine serum albumin
(BSA) according to the antibody manufacturer’s recommendations. Membranes
were probed using primary polyclonal anti-2SC antibody, prepared as described
previously (Nagai et al. 2007). The anti-Atg7 (#8558), anti-citrate-synthase
(#14309), anti-fumarase (#4567), anti-LC3 (#2775), and anti-α-tubulin [DM1A]
(#3873) primary antibodies used were from Cell Signaling (Cell Signaling,
Beverly, MA). The anti-GAPDH (#FL-335) primary antibody was from Santa Cruz
(Santa Cruz Biotechnology, Dallas, TX). The anti-Histone H3 (#05-928) primary
antibody was from EMD Millipore (EMD Millipore, Darmstadt, Germany). The
anti-VDAC2 (#GTX104745) primary antibody was from GeneTex (GeneTex,
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Irvine, CA). Horse radish peroxidase (HRP) labeled secondary antibodies were
used to detect the protein (Cell Signaling). Pierce® ECL 2 Western Blotting
Substrate was used to detect a chemiluminescent signal on photographic film
(Denville Scientific, Metuchen, NJ). ImageJ software (NIH) was used to quantify
band intensity by densitometry and normalize to α-tubulin levels.
5.7. Immunoprecipitation
Atg7 was immunoprecipitated from 400 µg of 5 mM and 30 mM glucose
treated cell lysates using a polyclonal anti-Atg 7 antibody (Cell Signaling #8558).
Samples were diluted in 400 µL RIPA buffer with 2 µL protease inhibitors and
pre-cleared with 10 µL Protein G magnetic beads (BioRad) on a Roto-Torque
(Cole-Parmer, Vernon Hills, IL) for 30 min at room temperature. 10 µL Protein G
magnetic beads were simultaneously incubated with 1.09 µg anti-Atg7 antibody
for 30 min at room temperature on the Roto-Torque. Following centrifugation of
the pre-cleared sample at 4000 x g for 2 min in a Heraeus Biofuge 13
microcentrifuge (Thermo Fisher Scientific), the samples were placed in magnetic
holder for 3 min. The supernatant was removed and added to the bead-antibody
complex and placed on the Roto-Torque for 35 min at room temperature. The
resulting bead-antibody-antigen complex was washed 3 times in 50 mM
phosphate buffer, pH 7.4, then re-suspended in 30 µL water with 8 µL Laemmli
loading buffer. The samples were boiled to separate the magnetic beads from the
protein-antibody complex and the supernatant was analyzed using onedimensional SDS-PAGE as described above. The immunoblots were probed with
polyclonal anti-2SC and anti-Atg7 antibodies.
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5.8. Data Analysis
Densitometric quantifications were performed in ImageJ (NIH). All graphs
were generated in Microsoft Excel.
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Appendix A
BUFFER PREPARATIONS
A.1. Homogenization Buffer
The buffer was prepared in 50 mL stocks containing 10 mM Tris Base,
10 mM MOPS, 1 mM EGTA, and 1 mM DTPA at pH 7.4 then 0.2 M sucrose was
added. On day of use, 2 mM sodium orthovanadate, 2 mM sodium fluoride and
protease inhibitor (1:1000) was added to the buffer. The buffer was stored at 4oC.
A.2. RIPA Buffer
The buffer was prepared in 200 mL stocks containing 50 mM Tris-HCl pH
8, 150 mM NaCl, 1% Triton-X, 0.5% sodium deoxycholate, 0.1% SDS, and 2 mM
EDTA. On day of use, 2 mM sodium orthovanadate, 2 mM sodium fluoride and
protease inhibitor (1:1000) was added to the buffer. The buffer was stored at 4 oC.
A.3. Running Buffer
One liter of 10x stock was prepared containing 250 mM Tris-HCl, 1920
mM glycine and 10% (SDS). Working solution contains 100 mL of 10x stock
diluted to 1 L with water.
A.4. Transfer Buffer
One liter of 10X stock was prepared containing 250 mM Tris-HCl, 1920
mM glycine. Working solution for transfer process contains 1x transfer buffer with
20% methanol.
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A.5. Wash Buffer
One liter of 10x stock was prepared containing 200 mM Tris-HCl, pH 7.4.
Tween-20 was added at 0.05% to 1x was buffer.
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Appendix B
LOWRY ASSAY
Pipette the specific amounts of reagents into the microplate in the order listed. All
samples are prepared in duplicates.
Table B.1: Preparation of BSA standard curve for the Lowry assay.
Copper
FolinBSA
H20
Reagent
Ciocolateu
Probe
(µL)
(µL)
(µL)
Incubation (µL)
Incubation
Blank

0

20

20

1

1

19

20

60
60
o

20 minutes at 37 C

2

2

18

20

3

3

17

20

60

4

4

16

20

60

5

8

12

20

60

6

10

10

20

60

7

20

0

20

60

15

20

60

Sample 5

60
30 minutes at 37oC

Stock BSA: Dissolve 50 mg BSA (Bovine Serum Albumin) in 10 mL deionized
water to get 5 mg/mL stock/working solution.
Working Solutions: Dilute 400 µL of 5 mg/mL stock in 600 µL water to get 2
mg/mL solution.
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Table B.2: Preparation of copper reagent for Lowry assay.
Stock Solution

Working Solution

Copper Sulfate 1% (w:v)

100 µL

Sodium Tartrate 2% (w:v)

100 µL

Sodium Carbonate 10% (w:v) in 0.5 M
NaOH
2 mL

Folin-Ciocolateu Phenol Reagent: Purchased as a 2 N stock solution. For
working solution at 500 µL of stock solution to 5.5 mL of water
Read absorbance at 660nm.
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Appendix C
WESTERN BLOTTING
C.1. Gel Electrophoresis
1. After determining the protein content from the Lowry assay, 10-40 µg of
protein was dissolved in water and 5 µL of Laemmli loading buffer was added.
2. Boil the samples for 15 min at 95°C then flash centrifuge.
3. Remove tape and comb from Bio-Rad pre cast Criterion gel and place in
cassette.
4. Fill the cassette tank and gel with Tris/Glycine/SDS running buffer.
5. Load the samples into their individual lanes and 10 µL of marker into your lane
of choice.
6. Run the gel at 200 V for 60 min.

C.2. Wet Transfer
1. Remove the gel from the pre-cast and cut to size
2. Soak the gel in Tris/Glycine/Methanol transfer buffer for 15 min.
3. Charge the PVDF membrane for ~1 minute in methanol. Soak the 2 pieces of
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blotting paper, 2 sponges, and the membrane in Tris/Glycine/methanol for 15
min.
4. Assemble the transfer apparatus, starting with the black side first. Keep all
materials soaking in transfer buffer during the assembly.
5. Place the sponge flat on the black side, followed by a piece of blotting paper.
Next, place the gel on top followed by the PVDF membrane. Roll out any air
bubbles between the gel and membrane using a roller. Finally, put the remaining
piece of blotting paper on top of the membrane and the sponge on top.
6. Assemble the apparatus and transfer at 250 mA for 100 min or 40 mA for at
least 12 hours.
7. Remove the membrane from the apparatus and wash with nanopure water.
8. Place the membrane in ponceau stain for 5 min then wash with nanopure
water to visualize the bands. Inspect the membrane for equal loading and where
bubbles formed during the transfer process. Wash the ponceau stain off the
membrane with Tris-HCl wash buffer.
9. Block the membrane in 5% non-fat dry milk or 5% BSA for at least 1hr.

C.3. Immunostaining
1. Prepare 1% milk by diluting the 5% milk 1:4 in Tris-HCl wash buffer or prepare
5% BSA.
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2. Add antibody to the milk or BSA in a 1:2000-1:10,000 dilution, see
manufacturer instruction. Incubate for at least 1 hour on the rocker.
3. Pour off the antibody and wash the membrane 3 times in 1x wash buffer for 5
min each.
4. Add secondary antibody (anti-rabbit or anti-mouse) to 1% milk or 5% BSA in a
1:500-20,000 dilution and incubate for 1hr at room temperature.
5. Pour off the milk or BSA and was the membrane 3 times for 5 min each in
wash buffer.

C.4. Developing Film
1. Prepare ECL solution by adding solution B to solution A and in a 1:40 dilution.
2. Add the ECL to the membrane and incubate for 5 min. Place the membrane in
the cassette and cover with plastic wrap.
3. In the dark room, place a piece of X-ray film over the membrane then develop.
Inspect the film after it has developed and adjust the exposure times accordingly.
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